[HTML][HTML] Gastrointestinal neuroendocrine tumors in 2020

M Ahmed - World journal of gastrointestinal oncology, 2020 - ncbi.nlm.nih.gov
Gastrointestinal neuroendocrine tumors are rare slow-growing tumors with distinct
histological, biological, and clinical characteristics that have increased in incidence and …

[HTML][HTML] Ki67 is a promising molecular target in the diagnosis of cancer

LT Li, G Jiang, Q Chen… - Molecular …, 2015 - build.spandidos-publications.com
The expression of Ki67 is strongly associated with tumor cell proliferation and growth, and is
widely used in routine pathological investigation as a proliferation marker. The nuclear …

The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors

JR Howe, NB Merchant, C Conrad, XM Keutgen… - Pancreas, 2020 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3

F Panzuto, J Ramage, DM Pritchard… - Journal of …, 2023 - Wiley Online Library
The aim of the present guidance paper was to update the previous ENETS guidelines on
well‐differentiated gastric and duodenal neuroendocrine tumours (NETs), providing …

Recent updates on grading and classification of neuroendocrine tumors

JY Kim, SM Hong, JY Ro - Annals of diagnostic pathology, 2017 - Elsevier
Neuroendocrine tumors (NETs) are originating from neuroendocrine cells in diffuse
endocrine systems. NETs are diagnosed by characteristic histologic features and …

Gastroenteropancreatic neuroendocrine tumours

IM Modlin, K Oberg, DC Chung, RT Jensen… - The lancet …, 2008 - thelancet.com
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms
that present many clinical challenges. They secrete peptides and neuroamines that cause …

[HTML][HTML] Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management

ZY Ma, YF Gong, HK Zhuang, ZX Zhou… - World journal of …, 2020 - ncbi.nlm.nih.gov
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with
complicated treatment options that depend on pathological grading, clinical staging, and …

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification …

MB Niederle, M Hackl, K Kaserer… - Endocrine-related …, 2010 - erc.bioscientifica.com
Germline inactivating mutations of isoform 4 of phosphodiesterase (PDE) 11A (coded by the
PDE11A gene) have been associated with familial adrenocortical tumors and familial …

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

G Rindi, G Klöppel, A Couvelard, P Komminoth… - Virchows Archiv, 2007 - Springer
Criteria for the staging and grading of neuroendocrine tumors (NETs) of midgut and hindgut
origin were established at the second Consensus Conference in Frascati (Rome) organized …

[HTML][HTML] Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National …

R Garcia-Carbonero, J Capdevila, G Crespo-Herrero… - Annals of oncology, 2010 - Elsevier
Abstract Background Neuroendocrine tumors (NETs) are an unusual family of neoplasms
with a wide and complex spectrum of clinical behavior. Here, we present the first report of a …